top of page


Aggiornamento: 12 mar 2022

Our NAFLD-on-a-chip model represents an advanced in vitro model to reproduce the early onset of NonAlcoholic Fatty Liver Disease (NAFLD) in a liver-on-a-chip microfluidic format.

In collaboration with Dr. Filippo Rossi (Politecnico di Milano, Italy) we are studying the potential of nanomedicine products in the management of NAFLD. In the video, a representative 3D stack of hepatic cells actively uptaking the nanovectors (in red).

9 visualizzazioni
bottom of page